Building coherence and synergy among global health initiatives by Fabio Zicker et al.
Zicker et al. Health Research Policy and Systems  (2015) 13:75 
DOI 10.1186/s12961-015-0062-3RESEARCH Open AccessBuilding coherence and synergy among
global health initiatives
Fabio Zicker1*, Miriam Faid1, John Reeder2 and Garry Aslanyan2Abstract
Background: The fast growth of global health initiatives (GHIs) has raised concerns regarding achievement of coherence
and synergy among distinct, complementary and sometimes competing activities. Herein, we propose an approach to
compare GHIs with regard to their main purpose and operational aspects, using the Special Programme for Research and
Training in Tropical Diseases (TDR/WHO) as a case study. The overall goal is to identify synergies and optimize efforts to
provide solutions to reduce the burden of diseases.
Methods: Twenty-six long-established GHIs were identified from among initiatives previously associated/partnered with
TDR/WHO. All GHIs had working streams that would benefit from linking to the capacity building or implementation
research focus of TDR. Individual profiles were created using a common template to collect information on relevant
parameters. For analytical purposes, GHIs were simultaneously clustered in five and eight groups according to
their ‘intended outcome’ and ‘operational framework’, respectively. A set of specific questions was defined to
assess coherence/alignment against a TDR reference profile by attributing a score, which was subsequently averaged
per GHI cluster. GHI alignment scores for intended outcome were plotted against scores for operational framework;
based on the analysis of coherence/alignment with TDR functions and operations, a risk level (high, medium or low) of
engagement was attributed to each GHI.
Results: The process allowed a bi-dimensional ranking of GHIs with regards to how adequately they fit with or match
TDR features and perspectives. Overall, more consistence was observed with regard to the GHIs’ main goals and
expected outcomes than with their operational aspects, reflecting the diversity of GHI business models. Analysis
of coherence indicated an increasing common trend for enhancing the engagement of developing country
stakeholders, building research capacity and optimization of knowledge management platforms in support of
improved access to healthcare.
Conclusions: The process used offers a broader approach that could be adapted by other GHIs to build coherence
and synergy with peer organizations and helps highlight the potential contribution of each GHI in the new era of
sustainable development goals. Emerging opportunities and new trends suggest that engagement between GHIs
should be selective and tailored to ensure efficient collaborations.
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The current dynamic and diverse global health scenario ex-
hibits a multitude of new actors, strategies and approaches
that offer new opportunities for engagement and synergy
[1–3]. Some global health initiatives (GHIs) were estab-
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mechanisms in the fulfilment of the abovementioned
functions. While some GHIs work as financing instru-
ments, most initiatives also focus on advocacy, coordin-
ation, technical support, and in research and product
development. Collectively, they open up a health develop-
ment space and engage an increasing number of new
actors and roles in global health for the benefit of poor
populations [5].
One of the pioneer initiatives established in 1974 was the
Special Programme of Research and Training in Tropical
Diseases (TDR), co-sponsored by UNDP, UNICEF, and
World Bank, and hosted by WHO. Over the years, TDR
has progressively shifted its strategic emphasis from sup-
porting basic biomedical research and product develop-
ment toward applied field research and implementation/
operational research, addressing issues related to access
and scaling-up of interventions in a range of poverty-
related diseases affecting neglected populations. Research
capacity strengthening has remained a strong strategic pil-
lar during this transition [6, 7]. Through its close working
relationship with a variety of stakeholders, and in consult-
ation with disease endemic countries and communities,
TDR has continuously reassessed where and how it could
make a difference [8]. Current core working areas of TDR
are capacity building, knowledge management, implemen-
tation research, and research in support of neglected trop-
ical disease control.
The evolving and expanding landscape posed the
pressing question of how TDR could best position itself
on the current global health scenario to optimize its im-
pact on public health. In addition, question emerged as
to how to anticipate the new landscape in the wake of
the coming United Nations Sustainable Development
Goals, in which health is considered as a precondition of a
broader agenda. As part of TDR’s review of its potential
strategic partnerships, a methodology was developed to
assess coherence and synergies among GHIs, with respect
to their ‘intended outcome’ and ‘operational framework’.
This paper offers a systematic review of key GHIs,
looking particularly at how they relate and complement
TDR, to assist in better-informed strategic choices.
While the purpose of this review was to help guide
TDR’s choices of scientific, technical and advocacy
partnerships, it offers a broader approach that could be
adapted by other GHIs to build coherence and synergy.
Methods
Selection of GHIs
Twenty-six long-established GHIs were identified by the
authors from among all initiatives associated/partnered
with TDR or WHO. All GHIs have working streams that
would benefit from linking to the capacity building or
implementation research focus of TDR.The selected GHIs have worldwide activities covering
a broad range of public health issues relevant to TDR,
and the largest overall budget. Other GHIs not fulfilling
these criteria, those which no longer reflect the core
working areas of TDR, or those with insufficient publi-
cally available information were excluded.
The sample included a broad and diverse representa-
tion of initiatives, including those with a national or
multinational scope, and of a public, private, for-profit,
or not-for-profit and provider or implementer nature
(see below). Due to the selection process, not all
current and past partners of TDR were included, but
the selection encompasses a wide representation of dif-
ferent types of GHIs.
Selected GHIs and acronyms (in alphabetical order)
1. The Bill & Melinda Gates Foundation (BMGF)
2. The Clinton Health Access Initiative (CHAI)
3. The Cochrane Collaboration (Cochrane)
4. Council on Health Research for Development
(COHRED)
5. GHI hosted by the UK Department for International
Development (DFID)
6. Drugs for Neglected Disease Initiative (DNDi)
7. European and Developing Countries Clinical Trials
Partnership (EDCTP)
8. Fogarty International Center - National Institutes
of Health (FIC)
9. Foundation for Innovative New Diagnostics (FIND)
10. Gavi, The Vaccine Alliance (Gavi)
11. The Global Fund to Fight AIDS, Tuberculosis and
Malaria (GFTAM)
12. Global Funding of Innovation for Neglected
Diseases (G-Finder)
13. Drug donation programmes in GlaxoSmithKline
plc. (GSK)
14. The EU Framework Programme for Research and
Innovation (Horizon 2020)
15. International Development Research Centre,
Canada (IDRC)
16. The Institute for Health Metrics and Evaluation
(IHME)
17. Medicines for Malaria Venture (MMV)
18. Drug donation programmes in Novartis
International AG (Novartis)
19. The President’s Malaria Initiative (PMI)
20. The Rockefeller Foundation (RF)
21. Roll Back Malaria (RBM)
22. Stop TB Partnership (Stop TB)
23. International Union Against Tuberculosis and Lung
Disease (The Union)
24. Innovative Financing for HIV, Malaria, TB
(UNITAID)
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Development (USAID)
26. The Wellcome Trust (WT)
GHI profiles
Individual GHI summary profiles were created using a
common template for collecting publically available infor-
mation on key parameters, referring to their purpose, as
well as functional and programmatic set-up. The informa-
tion collected included mandate, objectives, key guiding
principles/objectives, founding partners, business model,
priorities, decision-making body, prioritization processes,
decision-making processes for financial or technical sup-
port, diseases and technologies covered, modalities of direct
and indirect support, beneficiary geographical coverage,
capacity building activities, knowledge management, trans-
lation of research into policy, work outreach, and business
trend.
Clustering of GHIs
Given the diversity identified, and for better analytical
purposes, two groups of GHI clusters were formed based
on the profile created for each organization according to
the GHIs ‘intended outcome’ – describing what the GHI
seeks to achieve, and ‘operational framework’ – reflecting
the GHI business model, policy, process and activities.
The following concepts were adopted:
(1) Intended outcome sets out and defines what the
GHI seeks to achieve. It serves as a roadmap and
helps clarify the ‘raison d’être’ of the initiative, also
by means of strategizing on how to define targets
and achieve intermediary and final objectives. For
this paper, the intended outcome was obtained from
the GHIs information on its mandate, mission and
priorities. The following GHI clusters were defined
based on their intended outcome (a description of
each cluster is available in the Additional file 1 –
Description of GHI clusters).
 Access to products and services for health
 Knowledge management
 Product development
 Research and innovation
 Research and capacity development
(2) Operational framework refers to the GHI’s business
model, as well as to its policy, process, and
activities. It helps put the purpose of the initiative
into practice and guides the GHI on how it is being
run. For the purposes herein, the operational
framework was elaborated through the information
collected on mandate, mission, decision-making
processes at policy and strategy levels, and fundingmechanisms. The following GHI clusters were
defined based on their operational framework
(a description of each cluster is available in
Additional file 1 – Description of GHI clusters).
 Data platform
 GHI as foreign aid
 Innovative financing mechanism
 Drug donation within pharmaceutical company
 Philanthropic funding
 Public-private product research and development
 Scientific organization or programme
 Stakeholders coordination and support platform
Assessing coherence and alignment
To assess coherence and alignment against TDR’s form
and function, a set of specific questions was formulated
covering five broad areas (Table 1). Intendent outcome
was mapped through questions related to GHI overall ob-
jective and target. Operational framework was mapped
through questions related to the GHI processes, areas of
work, funding and outlook. A TDR reference profile was
established for each question and was used for direct com-
parison of GHIs (Additional file 2 – TDR Reference
profile).
Scoring
A 1–3 scale was used to assess the level of individual
GHI coherence/alignment against the established TDR
profile in relation to each question in Table 1. The indi-
vidual comparison allowed a score of 3 = full coherence/
alignment, 2 = partial, and 1 =minimum coherence/
alignment. The score was attributed through consensus
between two of the authors (FZ and MF), and involved a
third author (GA) in case of discordance. Total scores
were calculated for both individual and GHI clusters as
a summary measure of how adequately they fit or match
TDR’s characteristics.
A broad TDR subjective risk level for engagement was
attributed to each GHI (as low, medium, high) consider-
ing the potential conflict between mandates, interference
with governance and current alliances, conflict of inter-
est between partners, potential issues of ownership and
accountability, departure from WHO interest and TDR’s
priorities.
Results
The report offers a strategic approach to assess GHIs,
both individually and within the functional clusters,
reviewing key priority areas and added value. The quali-
tative assessment involved the following steps: (1) assess-
ment and scoring of individual GHIs against the TDR
reference profile for the first nine questions in Table 1,
which relate to intended outcome; (2) assessment and
Table 1 Assessment questions on coherence and alignment
with the Special Programme of Research and Training in
Tropical Diseases (TDR)
Overall objectives
Mandate Is the mandate of the GHI compatible with
TDR’s mandate?
Principles/values Are the guiding principles/values compatible
with TDR?
Priorities Are the priorities relevant for TDR and/or
reflect trending priorities in global health,
such as system approaches, preventions,




Do the nature and scope of membership
conflict with TDR’s interests?
Does the GHI operate through partnerships
and networks?
Inclusiveness Is there a balanced representation between




Is the diseases and technology profile/
portfolio compatible with TDR’s current
portfolio and possible expansion?
Beneficiary
geographical area
Are the beneficiaries of support compatible
with TDR’s focus?
Beneficiary eligibility To what extent would the beneficiaries
reinforce/expand the current scope of TDR?
Harmonization Are there attempts to harmonize process




Is the policy and strategy decision-making
process consistent with TDR’s principles?
Prioritization
(programme level)
Is the decision-making process at the
programmatic level consistent with TDR?
Decision-making
for grants
Is the decision-making process at the project
level consistent with TDR?
Business model Is there any aspect of the business model
that could restrict TDR from engaging?
Type of support Do the funding mechanisms conflict with TDR?
Can the funding mechanisms add value to
TDR?
Areas of work
Capacity building Would the range of capacity building
activities add a value to TDR’s current
approaches? If so, what kind of added value?
Knowledge
management
Would the range of knowledge management
add a value to TDR’s current approaches? If
so, what kind of added value?
Translational research Is the research and funding covering





Would engagement with the GHI add another
value for strengthening TDR’s influence in
global health (e.g. agenda setting, networking,
etc.)?
Table 1 Assessment questions on coherence and alignment
with the Special Programme of Research and Training in
Tropical Diseases (TDR) (Continued)
Funding Would the engagement with the GHI offer
the prospect of additional funding for TDR?
Business trend Is there a risk for TDR to engage with the
GHI? (e.g. sustainability, reputation costs)?
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profile for the subsequent 11 questions in Table 1, which
relate to operational framework; (3) summarizing two
total scores per GHI and an average for each cluster
(max score = 27 for nine questions on intended outcome
and max score = 33 for 11 questions on operational
framework); (4) attribute a TDR engagement risk group
(high, medium or low); and (5) plot total scores for
outcome versus framework for each GHI.
Table 2 shows how each particular GHI was classified/
clustered according to its intended outcome and
operational framework (see Additional file 1 for descrip-
tions of clusters).
Twelve GHIs were assigned to the group in which the
intended outcome was to improve access to products
and health services, although they operate through dif-
ferent approaches, such as direct technical and financial
support to programme planning and implementation,
drug donation, or as a coordination platform of the
multiple stakeholders. Most of these GHIs are closer to
public health action and have an important interaction
with country level stakeholders.
Three out of the four GHIs in the knowledge man-
agement group operate mainly as data platforms, con-
solidating and analysing information from multiple
sources. Three out of the four product development
initiatives reviewed are structured as public-private
partnerships, and the fourth (EDCTP) as a country
partnership initiative of the European Union. All four
interact with a broad range of research organizations.
The two GHI clusters with which TDR shares a strong
mandate affinity are ‘research and innovation’ and ‘re-
search and capacity development’. The three GHIs in
the research and innovation group have quite distinct
setting and operational frameworks (IDRC, BMGF and
Horizon 2020). Three GHIs share TDR’s intended out-
come on research and capacity development (RF, FIC
and WT), with FIC and WT being clustered as scientific
organization/programme and RF operating through a
philanthropic framework.
Other ways of clustering the GHIs reviewed in this re-
port, such as by target population, geographic or disease
focus, type of support, and primary role as funding or
implementing organization, could have been displayed
differently to highlight alternative interfaces. However,
the two parameters selected – ‘intended outcome’ and
Table 2 Global Health Initiatives (GHIs) classified by intended outcome and operational framework, respectively
GHIs full names are provided in Table 1.
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assess TDR positioning and potential collaboration.
Figure 1 plots two summary total alignment scores
for each GHI. Scores for intended outcome are plotted
against scores for operational framework. The scores
indicate how well the GHI matched a TDR reference
profile. Additional file 3 provides individual GHI and
cluster-based total scores.
In addition, the three levels of increasing risk were
colour coded. This allowed for a preliminary visualization
of the GHIs with regard to their potential strategic en-
gagement with TDR.Figure 1 Alignment/coherence total scores for intended outcome ver
for Research and Training in Tropical Diseases (TDR). Global Health InitThe best fit for coherence and alignment is repre-
sented by GHIs located in the top right corner and the
relatively less fitting initiatives would be in the bottom
left corner. It is notable that most of the GHIs with
best alignment are the ones with which TDR has more
recent work collaboration. The highest risk for engage-
ment was assigned to GHIs with the strongest independ-
ent governance and autonomy in which TDR would
possibly have more operational constraints. Most of them
are plotted in the bottom part of the graphic.
Figures 2 and 3 present the average coherence/alignment
scores for clusters of intended outcome and operationalsus operational framework in relation to the Special Programme
iatives’ full names are provided in Table 1.
Figure 2 Average coherence/alignment scores for the intended outcome cluster.
Figure 3 Average coherence/alignment scores for the operational framework cluster.
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of proposed intended outcome than by operational frame-
work. Product development GHIs were shown to have the
most identification with TDR in the expected outcome
cluster. Figure 3 indicates an inconsistent alignment
among the eight GHI groups with regard to operational
framework, which reflects the diversity of their business
models.
Discussion
This review comes at a particularly important time with
respect to the post-2015 development agenda debate that
will shape global health governance, including the role
and activities of GHIs [9]. The approach used herein
reveals areas of overlapping mandates and actions
among GHIs, highlighting the need for more coher-
ence, synergy and advocacy for a global health re-
search agenda.
The methodology used for reviewing the GHIs re-
vealed interfaces and opportunities for TDR to either
reinforce its engagement or initiate new collaborations
with the selected GHIs. No attempt was made to de-
scribe past and current engagements of TDR with the
GHIs reviewed in this report, in order to allow for an
objective assessment across all selected initiatives. The
result, however, was consistent in showing stronger
alignment for those GHIs with which TDR currently
enjoys productive engagement.
Concerning risk for engagement, it needs to be
highlighted that even long-term and reliable supporters
carry a risk when there is limited influence or control
of the GHIs on their own decision-making process and
sustainability.
A possible limitation of the analytical approach
used herein is the process of selecting the initiatives
to be included in the review. The inclusion criteria
should be adapted to the needs of the specific GHI
carrying out the mapping exercise of its best position
in the global landscape. It is hoped that critical
self-review by GHIs with regards to peer organiza-
tions would promote more coherence and synergetic
collaborations.
The analysis of coherence highlighted the following
notable trends shared by a number of initiatives:
 Overall interest in supporting research and capacity
development for improved healthcare access and
implementation at country level [10].
 Optimization of the use of knowledge management
platforms to assist in agenda setting and evidence-
based practice [11].
 Commitment to support research capacity
development as a component of large ongoing
health research and innovation initiatives [12]. Promotion and application of health system research
in support of equity, and better access to products
and health services [13].
 Reinforcement of the crucial role of developing
countries to promote outcome research in light of the
increased attention to Universal Health Coverage [14].
Given the fast-paced global health environment, GHIs
should pay close attention and continuously assess
emerging opportunities and new trends. Strategic en-
gagement should thus be selective and tailored in a way
that ensures efficient collaborative frameworks and
long-term goals in order to minimize risks and reduce
transaction costs and unwanted spin-offs.
While new GHIs will likely emerge in response to the
new global development architecture, many of the cur-
rently operating initiatives will also have to reassess how
their mandate and activities align with the Sustainable
Development Goals to ensure relevance and impact on
the newly set global health priorities.
Conclusion
Improving health in the new era of Sustainable Develop-
ment Goals will require leadership from all stakeholders.
GHIs may play a unique role ensuring coherence and
synergies across their activities, thus increasing the
impact when delivering their activities and influencing
global health in innovative and sustainable ways.
This review provides strategic information to facilitate
TDR in reassessing its potential to efficiently perform in
an increasingly complex global governance setting. It
also highlights the diversity of features among the
selected GHIs. The analytical framework used indicates
possible ways forward and stimulates the development
of alternative analytical approaches.
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